Kartik Ananth, MD
Interventional Pain Management · Torrance
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 26 years
- Graduated 2000
Offices
1 location · Revivex Healthcare Inc · 2 clinicians in this group
Hospitals listed: Torrance Memorial Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ananth’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A109016 · Current
Licensed to practise in California · since 2009 · expires 2026-12-31 · Autonomous University of Guadalajara Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Torrance Memorial Medical CenterTorrance, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.11 to 1.61), Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 15.79 (10.51 to 21.07) · 1,494 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.21 (0.72 to 1.71) · 9,154 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.328, Oct 2024 – Sep 2025
See every measure and the patient survey for Torrance Memorial Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.11 to 1.61) | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.79 (10.51 to 21.07) · 1,494 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.21 (0.72 to 1.71) · 9,154 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.328 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.72) · 2,154 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.72 (128.91 to 214.54) · 121 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 766 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 806 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 608 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 7,587 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.1 to 0.47) · 11,109 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.03 to 0.39) · 11,330 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.13 (2.41 to 5.85) · 2,964 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0.13 to 3.16) · 1,513 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.66 (1.3 to 4.01) · 2,802 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.24 (2.35 to 8.14) · 1,479 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.55 (0.11 to 2.98) · 650 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2 · 962 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.023 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.646 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.259 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.658 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 1,578 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 21.1 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 900 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.9 · 800 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,223 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.3) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7 to 15) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 928 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 316 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.5 to 16.1) · 624 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 781 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,607 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$342,937
Medicare paid this office $342,937 for 465 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 301 | $107,337 | $75 |
| Return visit (30+ min) | 143 | $64,226 | $99 |
| Psychotherapy with evaluation and management visit, 30 minutes | 113 | $31,549 | $59 |
| Injection of substance into lower spine canal using imaging guidance | 64 | $20,290 | $228 |
| Psychotherapy, 1 hour | 28 | $13,801 | $124 |
See all 28 services
| Short return visit (20+ min) | 301 | $107,337 | $75 |
| Return visit (30+ min) | 143 | $64,226 | $99 |
| Psychotherapy with evaluation and management visit, 30 minutes | 113 | $31,549 | $59 |
| Injection of substance into lower spine canal using imaging guidance | 64 | $20,290 | $228 |
| Psychotherapy, 1 hour | 28 | $13,801 | $124 |
| New patient visit (30+ min) | 144 | $13,500 | $94 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 38 | $13,000 | $224 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 19 | $9,762 | $390 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 24 | $7,472 | $192 |
| New patient visit (60+ min) | 34 | $5,807 | $171 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 19 | $5,378 | $215 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 28 | $3,969 | $99 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 22 | $3,579 | $99 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 15 | $3,093 | $141 |
| Review by radiologist of hip joint image | 16 | $2,700 | $117 |
| New patient visit (45+ min) | 16 | $2,137 | $134 |
| Injection of trigger points, 3 or more muscles | 29 | $2,029 | $51 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 18 | $1,992 | $87 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 19 | $1,440 | $53 |
| Testing for presence of drug, read by direct observation | 63 | $1,250 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $883 | $44 |
| Injection of drug or substance under skin or into muscle | 23 | $313 | $12 |
| Injection, methylprednisolone acetate, 80 mg | 16 | $154 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 111 | $149 | None |
| Injection, methylprednisolone acetate, 1 mg | 37 | $23 | None |
| Injection, fentanyl citrate, 0.1 mg | 15 | $20 | None |
| Injection, ketorolac tromethamine, per 15 mg | 15 | $15 | None |
| Injection, midazolam hydrochloride, per 1 mg | 23 | $7 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of substance into lower spine canal using imaging guidance | 99 | 90 | 109 | 85 | 134 | 89 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 33 | 36 | 38 | 30 | 79 | 58 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 22 | 33 | 33 | 26 | 60 | 40 |
| Injection of trigger points, 3 or more muscles | 17 | 28 | 29 | 28 | 35 | 40 |
| Injection of substance into middle or upper spine canal using imaging guidance | 29 | 38 | 29 | 29 | 35 | – |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | – | – | 23 | – | 35 | 39 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
465 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 14% · Women 61% · Also on Medicaid 11% · Health risk score 1.28. At or below the middle of the specialty; the typical interventional pain management clinician is at 1.37.
Conditions among them: High blood pressure 75% · Depression 42% · Diabetes 29% · Chronic kidney disease 26% · Coronary heart disease 22% · Heart failure 19% · Cancer 15% · Atrial fibrillation 14% · COPD 11% · Dementia 8% · Stroke 7%.
The office billed $2,622,777, Medicare allowed $445,865 and paid $342,937; for 5,723 services of 57 kinds; $368 of it was for drugs given in the office and $342,570 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 465 | 5,723 | 74 | 1.28 | $2,622,777 | $342,937 |
| 2023 | 479 | 7,054 | 74 | 1.28 | $1,890,879 | $351,180 |
| 2022 | 371 | 5,319 | 74 | 1.27 | $827,891 | $320,853 |
| 2021 | 327 | 4,254 | 73 | 1.33 | $607,873 | $217,599 |
| 2020 | 279 | 3,258 | 73 | 1.32 | $495,221 | $157,980 |
| 2019 | 314 | 3,079 | 73 | 1.35 | $400,971 | $126,544 |
| 2018 | 364 | 2,181 | 73 | 1.45 | $459,291 | $138,593 |
| 2017 | 391 | 2,335 | 74 | 1.36 | $427,292 | $159,395 |
| 2016 | 398 | 2,185 | 73 | 1.40 | $310,422 | $141,670 |
| 2015 | 465 | 3,068 | 72 | 1.40 | $346,993 | $172,986 |
| 2014 | 392 | 3,880 | 71 | 1.35 | $453,931 | $218,478 |
| 2013 | 249 | 2,460 | 70 | 1.46 | $507,695 | $138,268 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 27 services
| Short return visit (20+ min) | 317 | $79,429 | $56 |
| Return visit (30+ min) | 128 | $48,806 | $78 |
| Injection of substance into lower spine canal using imaging guidance | 90 | $30,502 | $228 |
| Psychotherapy with evaluation and management visit, 30 minutes | 111 | $28,258 | $50 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 46 | $17,524 | $222 |
| New patient visit (30+ min) | 178 | $16,426 | $92 |
| Psychotherapy, 1 hour | 27 | $13,535 | $107 |
| Injection of substance into middle or upper spine canal using imaging guidance | 24 | $8,313 | $238 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 11 | $7,003 | $412 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 23 | $6,327 | $181 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 35 | $6,013 | $100 |
| New patient visit (60+ min) | 28 | $4,223 | $151 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 11 | $3,881 | $204 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 17 | $3,806 | $146 |
| Injection of drug or substance under skin or into muscle | 136 | $2,926 | $12 |
| New patient visit (45+ min) | 23 | $2,897 | $126 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 20 | $2,802 | $93 |
| Review by radiologist of hip joint image | 18 | $2,664 | $121 |
| Injection of trigger points, 3 or more muscles | 25 | $1,822 | $52 |
| Long return visit (40+ min) | 11 | $1,527 | $139 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 99 | $1,404 | $9 |
| Testing for presence of drug, read by direct observation | 58 | $1,087 | $12 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 13 | $1,071 | $56 |
| Injection, methylprednisolone acetate, 80 mg | 55 | $942 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $641 | $46 |
| Injection, dexamethasone sodium phosphate, 1 mg | 151 | $236 | None |
| Injection, ketorolac tromethamine, per 15 mg | 53 | $49 | None |
2022: 23 services
| Short return visit (20+ min) | 240 | $81,757 | $73 |
| Return visit (30+ min) | 122 | $52,240 | $107 |
| Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | 11 | $33,133 | $105 |
| Psychotherapy with evaluation and management visit, 30 minutes | 81 | $23,636 | $59 |
| Injection of substance into lower spine canal using imaging guidance | 62 | $20,253 | $238 |
| Psychotherapy, 1 hour | 21 | $13,333 | $127 |
| New patient visit (30+ min) | 119 | $11,222 | $94 |
| Injection of substance into middle or upper spine canal using imaging guidance | 19 | $6,904 | $238 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 18 | $6,726 | $224 |
| New patient visit (45+ min) | 31 | $4,440 | $143 |
| New patient visit (60+ min) | 22 | $3,580 | $163 |
| Injection of drug or substance under skin or into muscle | 135 | $3,462 | $12 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 15 | $2,697 | $104 |
| Injection of substance into lower spine canal | 12 | $2,280 | $127 |
| Injection of trigger points, 3 or more muscles | 20 | $1,483 | $53 |
| Psychiatric services complicated by communication factor | 39 | $1,033 | $12 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 12 | $881 | $63 |
| Injection, methylprednisolone acetate, 80 mg | 27 | $384 | None |
| Testing for presence of drug, read by direct observation | 14 | $198 | $12 |
| Injection, dexamethasone sodium phosphate, 1 mg | 99 | $157 | None |
| Injection, ketorolac tromethamine, per 15 mg | 61 | $75 | None |
| Injection, fentanyl citrate, 0.1 mg | 12 | $40 | None |
| Injection, midazolam hydrochloride, per 1 mg | 15 | $3 | None |
2021: 21 services
| Short return visit (20+ min) | 249 | $86,063 | $78 |
| Injection of substance into lower spine canal using imaging guidance | 67 | $26,795 | $246 |
| Return visit (30+ min) | 93 | $15,434 | $106 |
| New patient visit (30+ min) | 97 | $9,334 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 23 | $8,561 | $225 |
| Injection of substance into middle or upper spine canal using imaging guidance | 19 | $7,063 | $244 |
| Psychotherapy, 1 hour | 11 | $4,683 | $130 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $4,457 | $194 |
| New patient visit (45+ min) | 31 | $4,328 | $140 |
| Injection of drug or substance under skin or into muscle | 140 | $3,984 | $13 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 21 | $3,406 | $103 |
| Psychiatric diagnostic evaluation with medical services | 13 | $2,169 | $167 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $2,130 | $97 |
| Injection of trigger points, 3 or more muscles | 15 | $1,623 | $56 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $1,281 | $61 |
| Psychotherapy with evaluation and management visit, 45 minutes | 12 | $988 | $76 |
| Injection, methylprednisolone acetate, 80 mg | 43 | $785 | None |
| Psychiatric services complicated by communication factor | 27 | $421 | $13 |
| Testing for presence of drug, read by direct observation | 18 | $239 | $13 |
| Injection, dexamethasone sodium phosphate, 1 mg | 96 | $193 | None |
| Injection, ketorolac tromethamine, per 15 mg | 54 | $68 | None |
2020: 14 services
| Short return visit (20+ min) | 225 | $61,228 | $62 |
| Injection of substance into lower spine canal using imaging guidance | 58 | $20,426 | $227 |
| Return visit (30+ min) | 74 | $10,025 | $86 |
| Injection of substance into middle or upper spine canal using imaging guidance | 23 | $8,950 | $236 |
| New patient visit (30+ min) | 89 | $7,957 | $89 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 26 | $7,623 | $212 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 24 | $3,140 | $95 |
| New patient visit (45+ min) | 13 | $1,778 | $137 |
| Injection of trigger points, 3 or more muscles | 15 | $1,380 | $49 |
| Injection of drug or substance under skin or into muscle | 55 | $960 | $12 |
| Injection, methylprednisolone acetate, 80 mg | 48 | $820 | None |
| Testing for presence of drug, read by direct observation | 20 | $274 | $12 |
| Injection, dexamethasone sodium phosphate, 1 mg | 84 | $128 | None |
| Injection, ketorolac tromethamine, per 15 mg | 37 | $42 | None |
2019: 15 services
| Short return visit (20+ min) | 253 | $46,393 | $62 |
| Injection of substance into lower spine canal using imaging guidance | 65 | $22,730 | $230 |
| Return visit (30+ min) | 77 | $10,401 | $90 |
| New patient visit (30+ min) | 87 | $7,935 | $91 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 24 | $7,138 | $216 |
| Injection of substance into middle or upper spine canal using imaging guidance | 18 | $6,720 | $232 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 13 | $2,114 | $151 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $1,997 | $91 |
| Psychiatric diagnostic evaluation with medical services | 15 | $1,984 | $132 |
| Injection of drug or substance under skin or into muscle | 40 | $975 | $15 |
| Injection of trigger points, 3 or more muscles | 12 | $858 | $50 |
| Injection, methylprednisolone acetate, 80 mg | 46 | $650 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 101 | $130 | None |
| Injection, ketorolac tromethamine, per 15 mg | 77 | $94 | None |
| Injection, midazolam hydrochloride, per 1 mg | 18 | $4 | None |
2018: 17 services
| Short return visit (20+ min) | 284 | $47,339 | $58 |
| Injection of substance into lower spine canal using imaging guidance | 68 | $20,331 | $212 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 43 | $11,311 | $189 |
| New patient visit (30+ min) | 114 | $9,881 | $87 |
| Injection of substance into middle or upper spine canal using imaging guidance | 18 | $5,654 | $217 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 12 | $5,076 | $363 |
| Return visit (30+ min) | 44 | $4,568 | $82 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 33 | $3,591 | $80 |
| Injection of drug or substance under skin or into muscle | 114 | $2,913 | $18 |
| New patient visit (45+ min) | 14 | $1,936 | $138 |
| Injection of trigger points, 3 or more muscles | 17 | $1,146 | $55 |
| Psychiatric diagnostic evaluation with medical services | 12 | $1,107 | $92 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $595 | $46 |
| Review by radiologist of hip joint image | 12 | $338 | $24 |
| Injection, ketorolac tromethamine, per 15 mg | 112 | $139 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 129 | $21 | None |
| Injection, midazolam hydrochloride, per 1 mg | 21 | $4 | None |
2017: 16 services
| Short return visit (20+ min) | 313 | $55,594 | $60 |
| Injection of substance into lower spine canal using imaging guidance | 65 | $22,845 | $218 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 45 | $13,946 | $199 |
| New patient visit (30+ min) | 118 | $10,563 | $90 |
| Injection of substance into middle or upper spine canal using imaging guidance | 28 | $8,619 | $221 |
| Return visit (30+ min) | 58 | $5,537 | $70 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 37 | $4,716 | $79 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 17 | $4,130 | $180 |
| New patient visit (45+ min) | 18 | $2,314 | $129 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $1,746 | $87 |
| Injection of drug or substance under skin or into muscle | 51 | $1,482 | $22 |
| Injection, methylprednisolone acetate, 80 mg | 98 | $1,236 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $606 | $47 |
| Injection, ketorolac tromethamine, per 15 mg | 114 | $173 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 46 | $6 | None |
| Injection, midazolam hydrochloride, per 1 mg | 21 | $5 | None |
2016: 13 services
| Short return visit (20+ min) | 328 | $56,668 | $60 |
| Injections of substances into lower or sacral spine | 71 | $19,538 | $197 |
| New patient visit (30+ min) | 142 | $13,202 | $93 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 42 | $11,561 | $193 |
| Injections of substances into upper or middle spine | 25 | $7,436 | $212 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 35 | $3,652 | $78 |
| Return visit (30+ min) | 31 | $2,502 | $58 |
| Injection, methylprednisolone acetate, 80 mg | 134 | $1,480 | None |
| New patient visit (45+ min) | 12 | $1,284 | $107 |
| Injection of trigger points, 3 or more muscles | 16 | $1,008 | $56 |
| Injection of drug or substance under skin or into muscle | 22 | $518 | $22 |
| Injection, ketorolac tromethamine, per 15 mg | 120 | $166 | None |
| Injection, midazolam hydrochloride, per 1 mg | 20 | $4 | None |
2015: 19 services
| Short return visit (20+ min) | 350 | $54,076 | $58 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 63 | $19,227 | $188 |
| Injections of substances into lower or sacral spine | 62 | $17,163 | $191 |
| New patient visit (30+ min) | 192 | $16,844 | $88 |
| Return visit (30+ min) | 126 | $16,036 | $84 |
| Injections of substances into upper or middle spine | 24 | $7,569 | $210 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 57 | $7,523 | $75 |
| Psychiatric diagnostic evaluation with medical services | 25 | $2,537 | $101 |
| New patient visit (45+ min) | 18 | $2,106 | $117 |
| Injection of trigger points, 3 or more muscles | 23 | $1,566 | $52 |
| Injection, methylprednisolone acetate, 80 mg | 149 | $1,378 | None |
| Fluoroscopic guidance for spine or back muscle injection | 11 | $888 | $74 |
| Injection of drug or substance under skin or into muscle | 31 | $857 | $21 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 11 | $402 | $34 |
| Injection, ketorolac tromethamine, per 15 mg | 154 | $261 | None |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 13 | $129 | None |
| Injection, meperidine hydrochloride, per 100 mg | 17 | $67 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $14 | None |
| Injection, midazolam hydrochloride, per 1 mg | 32 | $7 | None |
2014: 24 services
| Short return visit (20+ min) | 294 | $56,195 | $60 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 70 | $18,594 | $202 |
| New patient visit (30+ min) | 168 | $15,199 | $90 |
| Return visit (30+ min) | 106 | $12,714 | $86 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 67 | $8,683 | $79 |
| New patient visit (45+ min) | 46 | $6,328 | $138 |
| Psychotherapy with evaluation and management visit, 30 minutes | 42 | $4,670 | $51 |
| Psychiatric diagnostic evaluation with medical services | 40 | $4,542 | $114 |
| Injection of trigger points, 3 or more muscles | 44 | $3,903 | $55 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 29 | $3,818 | $106 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $2,861 | $168 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 29 | $2,722 | $47 |
| Short return visit | 27 | $2,037 | $37 |
| Injections of substances into lower or sacral spine | 17 | $1,976 | $94 |
| Psychiatric diagnostic evaluation | 17 | $1,881 | $111 |
| Injection of drug or substance under skin or into muscle | 65 | $1,798 | $21 |
| Review by radiologist of hip joint image | 16 | $1,773 | $93 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 74 | $1,705 | None |
| Fluoroscopic guidance for spine or back muscle injection | 16 | $1,604 | $80 |
| Ultrasonic guidance for needle placement | 13 | $1,227 | $65 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $1,219 | $87 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 48 | $363 | None |
| Injection, ketorolac tromethamine, per 15 mg | 133 | $143 | None |
| Injection, meperidine hydrochloride, per 100 mg | 24 | $133 | None |
2013: 23 services
| Return visit (30+ min) | 137 | $32,785 | $87 |
| Short return visit (20+ min) | 127 | $12,923 | $57 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 34 | $10,339 | $211 |
| New patient visit (45+ min) | 64 | $8,536 | $133 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 33 | $7,730 | $83 |
| New patient visit (30+ min) | 74 | $6,160 | $83 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $2,453 | $107 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $2,410 | $185 |
| Psychotherapy with evaluation and management visit, 30 minutes | 40 | $2,054 | $27 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 16 | $2,001 | $105 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 16 | $1,695 | $46 |
| Fluoroscopic guidance for spine or back muscle injection | 14 | $1,274 | $85 |
| Injection of trigger points, 3 or more muscles | 21 | $1,255 | $55 |
| Psychiatric diagnostic evaluation with medical services | 12 | $1,218 | $102 |
| Injection of drug or substance under skin or into muscle | 41 | $1,166 | $21 |
| Review by radiologist of hip joint image | 11 | $1,161 | $97 |
| Short return visit | 28 | $1,103 | $34 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $1,024 | $93 |
| Aspiration and/or injection of fluid from medium joint | 14 | $932 | $49 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 67 | $850 | None |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 11 | $118 | None |
| Injection, ketorolac tromethamine, per 15 mg | 78 | $78 | None |
| Injection, meperidine hydrochloride, per 100 mg | 19 | $45 | None |
Medicaid work
$79 in 2023
Medicaid paid $79 for 33 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 33 | $79 |
| 2023 | 33 | 1 | 15 | $79 |
Drugs they prescribed that Part D paid
$20,767
Pharmacies billed $20,767 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 34% of their Part D prescriptions (104 of 307) in 2024. At or below the middle of the specialty; the typical interventional pain management clinician is at 49%.
297 generic and fewer than 11 brand-name prescriptions · $20,767 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 45 | $804 | $18 |
| Oxycodone-Acetaminophen | 25 | $575 | $23 |
| Duloxetine | 16 | $489 | $31 |
| Gabapentin | 33 | $324 | $10 |
| Tizanidine | 11 | $203 | $18 |
See all 7 drugs
| Hydrocodone-Acetaminophen | 45 | $804 | $18 |
| Oxycodone-Acetaminophen | 25 | $575 | $23 |
| Duloxetine | 16 | $489 | $31 |
| Gabapentin | 33 | $324 | $10 |
| Tizanidine | 11 | $203 | $18 |
| Tramadol | 17 | $47 | $3 |
| Meloxicam | 29 | $24 | $1 |
Year by year
| 2024 | 307 | 130 | 34% (104) | None | $20,767 |
| 2023 | 747 | 196 | 38% (284) | 6% | $78,177 |
| 2022 | 1,839 | 242 | 44% (805) | 6% | $192,778 |
| 2021 | 1,935 | 195 | 40% (764) | 5% | $181,160 |
| 2020 | 2,015 | 197 | 41% (818) | 8% | $223,047 |
| 2019 | 1,769 | 211 | 43% (755) | 7% | $197,661 |
| 2018 | 1,715 | 216 | 42% (711) | 9% | $195,698 |
| 2017 | 1,614 | 212 | 46% (745) | 10% | $162,893 |
| 2016 | 1,729 | 229 | 46% (802) | 11% | $193,493 |
| 2015 | 1,873 | 252 | 43% (799) | 14% | $203,833 |
| 2014 | 1,829 | 225 | 32% (583) | 16% | $215,148 |
| 2013 | 1,180 | 164 | 34% (396) | None | $84,292 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Gabapentin | 93 | $2,961 | $32 |
| Lidocaine | 16 | $2,869 | $179 |
| Hydrocodone-Acetaminophen | 121 | $2,616 | $22 |
| Oxycodone-Acetaminophen | 60 | $1,795 | $30 |
| Fentanyl | 13 | $1,758 | $135 |
| Tizanidine | 22 | $1,296 | $59 |
| Morphine Sulfate Er | 19 | $1,118 | $59 |
| Duloxetine | 43 | $1,076 | $25 |
| Pregabalin | 28 | $932 | $33 |
| Buprenorphine | 18 | $664 | $37 |
| Cyclobenzaprine | 24 | $371 | $15 |
| Meloxicam | 40 | $171 | $4 |
| Quetiapine | 16 | $162 | $10 |
| Tramadol | 38 | $110 | $3 |
| Baclofen | 11 | $103 | $9 |
| Trazodone | 13 | $83 | $6 |
2022: 37 drugs
| Nucynta Er | 13 | $15,494 | $1,192 |
| Movantik | 22 | $9,036 | $411 |
| Buprenorphine-Naloxone | 35 | $8,389 | $240 |
| Hydrocodone-Acetaminophen | 338 | $6,093 | $18 |
| Oxycodone-Acetaminophen | 180 | $6,073 | $34 |
| Lidocaine | 29 | $5,603 | $193 |
| Fentanyl | 48 | $4,871 | $101 |
| Gabapentin | 184 | $4,717 | $26 |
| Duloxetine | 59 | $3,878 | $66 |
| Aripiprazole | 13 | $3,001 | $231 |
| Morphine Sulfate Er | 65 | $2,631 | $40 |
| Pregabalin | 51 | $2,347 | $46 |
| Buprenorphine | 40 | $1,695 | $42 |
| Celecoxib | 14 | $1,215 | $87 |
| Diclofenac | 32 | $874 | $27 |
| Tizanidine | 65 | $688 | $11 |
| Acetaminophen-Codeine | 11 | $591 | $54 |
| Buspirone | 20 | $537 | $27 |
| Bupropion Xl | 17 | $449 | $26 |
| Hydromorphone | 18 | $413 | $23 |
| Escitalopram | 25 | $392 | $16 |
| Cyclobenzaprine | 49 | $387 | $8 |
| Venlafaxine Hcl Er | 16 | $384 | $24 |
| Morphine Sulfate | 12 | $367 | $31 |
| Trazodone | 44 | $322 | $7 |
| Amitriptyline | 16 | $239 | $15 |
| Tramadol | 103 | $225 | $2 |
| Baclofen | 20 | $217 | $11 |
| Ibuprofen | 16 | $198 | $12 |
| Quetiapine | 20 | $171 | $9 |
| Meloxicam | 37 | $162 | $4 |
| Dextroamphetamine-Amphetamine | 11 | $135 | $12 |
| Methylprednisolone | 16 | $117 | $7 |
| Sumatriptan | 11 | $60 | $5 |
| Clonidine | 13 | $54 | $4 |
| Lorazepam | 14 | $23 | $2 |
| Alprazolam | 11 | $22 | $2 |
2021: 38 drugs
| Belsomra | 12 | $4,921 | $410 |
| Hydrocodone-Acetaminophen | 329 | $4,884 | $15 |
| Aripiprazole | 53 | $4,537 | $86 |
| Oxycodone-Acetaminophen | 141 | $4,190 | $30 |
| Gabapentin | 169 | $3,606 | $21 |
| Pregabalin | 55 | $3,103 | $56 |
| Fentanyl | 36 | $2,905 | $81 |
| Duloxetine | 88 | $2,738 | $31 |
| Lidocaine | 12 | $2,719 | $227 |
| Morphine Sulfate Er | 69 | $2,677 | $39 |
| Buprenorphine-Naloxone | 18 | $2,300 | $128 |
| Hydromorphone Er | 11 | $2,143 | $195 |
| Celecoxib | 14 | $1,598 | $114 |
| Hydromorphone | 31 | $788 | $25 |
| Buprenorphine | 16 | $772 | $48 |
| Venlafaxine Hcl Er | 39 | $746 | $19 |
| Bupropion Xl | 33 | $732 | $22 |
| Clozapine | 12 | $707 | $59 |
| Baclofen | 15 | $647 | $43 |
| Tizanidine | 56 | $645 | $12 |
| Trazodone | 67 | $575 | $9 |
| Cyclobenzaprine | 48 | $570 | $12 |
| Diclofenac | 15 | $555 | $37 |
| Tramadol | 88 | $497 | $6 |
| Escitalopram | 45 | $464 | $10 |
| Mirtazapine | 16 | $385 | $24 |
| Sertraline | 18 | $306 | $17 |
| Buspirone | 20 | $284 | $14 |
| Amitriptyline | 16 | $264 | $16 |
| Dextroamphetamine-Amphetamine | 14 | $263 | $19 |
| Quetiapine | 28 | $239 | $9 |
| Clonazepam | 30 | $228 | $8 |
| Oxycodone | 16 | $200 | $12 |
| Lorazepam | 35 | $192 | $5 |
| Zolpidem | 19 | $111 | $6 |
| Alprazolam | 16 | $66 | $4 |
| Diazepam | 13 | $65 | $5 |
| Meloxicam | 26 | $64 | $2 |
2020: 43 drugs
| Wellbutrin Xl | None | 11 | $46,387 | $4,217 |
| Xtampza Er | None | 13 | $10,237 | $787 |
| Aimovig | Migraine | 12 | $8,163 | $680 |
| Aripiprazole | None | 40 | $7,467 | $187 |
| Hydrocodone-Acetaminophen | None | 314 | $5,059 | $16 |
| Oxycodone-Acetaminophen | None | 146 | $4,476 | $31 |
| Belsomra | None | 11 | $4,241 | $386 |
| Vyvanse | None | 12 | $4,093 | $341 |
| Duloxetine | None | 92 | $3,734 | $41 |
| Gabapentin | None | 167 | $3,718 | $22 |
| Morphine Sulfate Er | None | 90 | $3,234 | $36 |
| Fentanyl | None | 29 | $3,163 | $109 |
| Pregabalin | None | 49 | $3,102 | $63 |
| Buprenorphine | None | 21 | $2,535 | $121 |
| Hydromorphone Er | None | 12 | $2,338 | $195 |
| Sumatriptan | None | 13 | $1,267 | $97 |
| Bupropion Xl | None | 36 | $901 | $25 |
| Tizanidine | None | 53 | $764 | $14 |
| Baclofen | None | 16 | $762 | $48 |
| Venlafaxine Hcl Er | None | 24 | $761 | $32 |
| Diclofenac | None | 22 | $663 | $30 |
| Hydromorphone | None | 22 | $628 | $29 |
| Tramadol | None | 118 | $596 | $5 |
| Escitalopram | None | 58 | $578 | $10 |
| Buspirone | None | 22 | $532 | $24 |
| Mirtazapine | None | 20 | $446 | $22 |
| Trazodone | None | 52 | $446 | $9 |
| Lamotrigine | None | 11 | $439 | $40 |
| Cyclobenzaprine | None | 19 | $430 | $23 |
| Quetiapine | None | 20 | $422 | $21 |
| Methylphenidate | None | 12 | $400 | $33 |
| Clozapine | None | 16 | $307 | $19 |
| Sertraline | None | 21 | $295 | $14 |
| Dextroamphetamine-Amphetamine | None | 14 | $253 | $18 |
| Alprazolam | None | 27 | $227 | $8 |
| Amitriptyline | None | 14 | $213 | $15 |
| Oxycodone | None | 15 | $210 | $14 |
| Clonazepam | None | 32 | $209 | $7 |
| Meloxicam | None | 40 | $191 | $5 |
| Hydrocodone-Ibuprofen | None | 11 | $174 | $16 |
| Lorazepam | None | 48 | $155 | $3 |
| Diazepam | None | 21 | $131 | $6 |
| Zolpidem | None | 24 | $62 | $3 |
2019: 43 drugs
| Levorphanol | 14 | $48,705 | $3,479 |
| Lyrica | 25 | $17,916 | $717 |
| Aripiprazole | 52 | $8,266 | $159 |
| Belsomra | 21 | $7,815 | $372 |
| Duloxetine | 104 | $5,061 | $49 |
| Vyvanse | 13 | $4,214 | $324 |
| Oxycodone-Acetaminophen | 143 | $3,653 | $26 |
| Hydrocodone-Acetaminophen | 249 | $3,628 | $15 |
| Gabapentin | 130 | $3,610 | $28 |
| Lidocaine | 11 | $3,440 | $313 |
| Buprenorphine-Naloxone | 16 | $3,425 | $214 |
| Fentanyl | 27 | $2,907 | $108 |
| Morphine Sulfate Er | 78 | $2,338 | $30 |
| Hydromorphone Er | 13 | $2,306 | $177 |
| Endocet | 35 | $1,451 | $41 |
| Pregabalin | 14 | $965 | $69 |
| Tramadol | 111 | $962 | $9 |
| Bupropion Xl | 32 | $948 | $30 |
| Dextroamphetamine-Amphetamine | 15 | $918 | $61 |
| Celecoxib | 14 | $843 | $60 |
| Venlafaxine Hcl Er | 22 | $591 | $27 |
| Escitalopram | 46 | $578 | $13 |
| Methylphenidate | 12 | $564 | $47 |
| Tizanidine | 22 | $428 | $19 |
| Buspirone | 18 | $405 | $23 |
| Clozapine | 21 | $394 | $19 |
| Diclofenac | 14 | $393 | $28 |
| Fluoxetine | 21 | $345 | $16 |
| Trazodone | 28 | $310 | $11 |
| Mirtazapine | 13 | $304 | $23 |
| Lorazepam | 43 | $300 | $7 |
| Meloxicam | 52 | $274 | $5 |
| Methadone | 14 | $253 | $18 |
| Sertraline | 12 | $249 | $21 |
| Amitriptyline | 22 | $210 | $10 |
| Oxycodone | 12 | $180 | $15 |
| Zolpidem | 12 | $146 | $12 |
| Clonazepam | 30 | $141 | $5 |
| Hydrocodone-Ibuprofen | 12 | $135 | $11 |
| Cyclobenzaprine | 13 | $128 | $10 |
| Acetaminophen-Codeine | 11 | $108 | $10 |
| Diazepam | 15 | $91 | $6 |
| Alprazolam | 18 | $88 | $5 |
2018: 38 drugs
| Levorphanol | 21 | $69,338 | $3,302 |
| Lyrica | 44 | $33,202 | $755 |
| Nucynta Er | 12 | $11,357 | $946 |
| Aripiprazole | 50 | $7,089 | $142 |
| Belsomra | 20 | $7,043 | $352 |
| Duloxetine | 150 | $6,266 | $42 |
| Hydrocodone-Acetaminophen | 233 | $4,442 | $19 |
| Oxycodone-Acetaminophen | 128 | $4,119 | $32 |
| Hydromorphone Er | 12 | $4,093 | $341 |
| Buprenorphine-Naloxone | 15 | $4,030 | $269 |
| Vyvanse | 12 | $3,795 | $316 |
| Gabapentin | 116 | $2,475 | $21 |
| Fentanyl | 27 | $2,297 | $85 |
| Morphine Sulfate Er | 58 | $2,073 | $36 |
| Celecoxib | 23 | $1,833 | $80 |
| Bupropion Xl | 35 | $1,434 | $41 |
| Tramadol | 103 | $1,237 | $12 |
| Clozapine | 25 | $718 | $29 |
| Venlafaxine Hcl Er | 36 | $564 | $16 |
| Methadone | 23 | $561 | $24 |
| Escitalopram | 54 | $555 | $10 |
| Baclofen | 15 | $498 | $33 |
| Oxycodone | 28 | $483 | $17 |
| Risperidone | 13 | $453 | $35 |
| Methylphenidate | 11 | $433 | $39 |
| Hydromorphone | 27 | $336 | $12 |
| Tizanidine | 20 | $251 | $13 |
| Trazodone | 35 | $248 | $7 |
| Alprazolam | 24 | $232 | $10 |
| Lorazepam | 32 | $209 | $7 |
| Endocet | 11 | $199 | $18 |
| Divalproex | 12 | $193 | $16 |
| Hydrocodone-Ibuprofen | 12 | $171 | $14 |
| Methylprednisolone | 13 | $128 | $10 |
| Fluoxetine | 15 | $125 | $8 |
| Sertraline | 12 | $112 | $9 |
| Meloxicam | 28 | $81 | $3 |
| Clonazepam | 28 | $71 | $3 |
2017: 33 drugs
| Lyrica | 39 | $25,018 | $641 |
| Aripiprazole | 37 | $8,370 | $226 |
| Oxycodone-Acetaminophen | 137 | $5,028 | $37 |
| Buprenorphine-Naloxone | 14 | $4,384 | $313 |
| Hydrocodone-Acetaminophen | 239 | $3,787 | $16 |
| Morphine Sulfate Er | 71 | $3,384 | $48 |
| Gabapentin | 124 | $3,356 | $27 |
| Duloxetine | 83 | $3,322 | $40 |
| Vyvanse | 12 | $3,247 | $271 |
| Fentanyl | 25 | $2,364 | $95 |
| Bupropion Xl | 33 | $1,041 | $32 |
| Clozapine | 25 | $907 | $36 |
| Oxycodone | 45 | $885 | $20 |
| Tramadol | 72 | $777 | $11 |
| Hydromorphone | 52 | $738 | $14 |
| Methylphenidate | 12 | $725 | $60 |
| Baclofen | 28 | $651 | $23 |
| Amitriptyline | 26 | $583 | $22 |
| Buspirone | 13 | $520 | $40 |
| Methadone | 20 | $357 | $18 |
| Venlafaxine Hcl Er | 14 | $317 | $23 |
| Trazodone | 31 | $261 | $8 |
| Escitalopram | 26 | $255 | $10 |
| Methylprednisolone | 16 | $234 | $15 |
| Tizanidine | 16 | $189 | $12 |
| Eszopiclone | 14 | $186 | $13 |
| Sertraline | 17 | $170 | $10 |
| Hydrocodone-Ibuprofen | 13 | $165 | $13 |
| Meloxicam | 37 | $164 | $4 |
| Cyclobenzaprine | 11 | $144 | $13 |
| Mirtazapine | 13 | $130 | $10 |
| Clonazepam | 40 | $118 | $3 |
| Lorazepam | 27 | $85 | $3 |
2016: 38 drugs
| Aripiprazole | 32 | $18,241 | $570 |
| Opana Er | 21 | $15,883 | $756 |
| Lyrica | 30 | $13,787 | $460 |
| Oxycodone-Acetaminophen | 151 | $8,253 | $55 |
| Hydrocodone-Acetaminophen | 254 | $7,005 | $28 |
| Oxycontin | 18 | $5,853 | $325 |
| Fentanyl | 54 | $5,315 | $98 |
| Duloxetine | 92 | $5,291 | $58 |
| Morphine Sulfate Er | 75 | $4,379 | $58 |
| Gabapentin | 137 | $3,034 | $22 |
| Vyvanse | 12 | $2,979 | $248 |
| Hydromorphone | 59 | $1,492 | $25 |
| Bupropion Xl | 33 | $1,012 | $31 |
| Dextroamphetamine-Amphetamine | 15 | $714 | $48 |
| Escitalopram | 38 | $688 | $18 |
| Baclofen | 26 | $678 | $26 |
| Oxycodone | 38 | $671 | $18 |
| Tramadol | 54 | $579 | $11 |
| Oxcarbazepine | 11 | $553 | $50 |
| Tizanidine | 18 | $487 | $27 |
| Clozapine | 13 | $470 | $36 |
| Methadone | 25 | $469 | $19 |
| Etodolac | 13 | $443 | $34 |
| Buspirone | 13 | $438 | $34 |
| Amitriptyline | 15 | $406 | $27 |
| Venlafaxine Hcl Er | 13 | $309 | $24 |
| Methylprednisolone | 18 | $257 | $14 |
| Sertraline | 23 | $240 | $10 |
| Zolpidem | 27 | $190 | $7 |
| Lorazepam | 36 | $171 | $5 |
| Mirtazapine | 12 | $148 | $12 |
| Clonazepam | 44 | $136 | $3 |
| Alprazolam | 25 | $135 | $5 |
| Citalopram Hbr | 16 | $118 | $7 |
| Trazodone | 20 | $102 | $5 |
| Meloxicam | 30 | $77 | $3 |
| Diazepam | 11 | $74 | $7 |
| Cyclobenzaprine | 11 | $44 | $4 |
2015: 37 drugs
| Duloxetine | 133 | $13,001 | $98 |
| Opana Er | 21 | $11,814 | $563 |
| Aripiprazole | 17 | $11,564 | $680 |
| Morphine Sulfate Er | 86 | $9,786 | $114 |
| Lyrica | 21 | $9,332 | $444 |
| Oxycodone-Acetaminophen | 127 | $8,267 | $65 |
| Fentanyl | 61 | $6,800 | $111 |
| Hydrocodone-Acetaminophen | 231 | $6,666 | $29 |
| Butrans | 14 | $5,874 | $420 |
| Oxycontin | 16 | $4,561 | $285 |
| Gabapentin | 129 | $4,384 | $34 |
| Hydromorphone | 88 | $2,815 | $32 |
| Bupropion Xl | 35 | $1,192 | $34 |
| Methadone | 35 | $1,131 | $32 |
| Oxycodone | 25 | $1,115 | $45 |
| Dextroamphetamine-Amphetamine | 21 | $938 | $45 |
| Morphine Sulfate | 25 | $888 | $36 |
| Acetaminophen-Codeine | 18 | $630 | $35 |
| Tramadol | 43 | $519 | $12 |
| Cyclobenzaprine | 19 | $493 | $26 |
| Escitalopram | 50 | $489 | $10 |
| Tizanidine | 12 | $447 | $37 |
| Alprazolam | 59 | $437 | $7 |
| Quetiapine | 24 | $415 | $17 |
| Venlafaxine Hcl Er | 27 | $403 | $15 |
| Clonazepam | 56 | $397 | $7 |
| Amitriptyline | 15 | $331 | $22 |
| Lorazepam | 43 | $278 | $6 |
| Alprazolam Er | 11 | $273 | $25 |
| Zolpidem | 34 | $270 | $8 |
| Sertraline | 21 | $263 | $13 |
| Mirtazapine | 20 | $240 | $12 |
| Fluoxetine | 13 | $223 | $17 |
| Diazepam | 19 | $96 | $5 |
| Citalopram Hbr | 14 | $84 | $6 |
| Meloxicam | 11 | $76 | $7 |
| Trazodone | 17 | $68 | $4 |
2014: 40 drugs
| Abilify | 44 | $45,497 | $1,034 |
| Duloxetine | 102 | $18,577 | $182 |
| Opana Er | 32 | $15,625 | $488 |
| Lyrica | 29 | $9,538 | $329 |
| Oxycontin | 13 | $7,572 | $582 |
| Cymbalta | 23 | $7,117 | $309 |
| Hydrocodone-Acetaminophen | 209 | $5,317 | $25 |
| Oxycodone-Acetaminophen | 65 | $4,349 | $67 |
| Oxymorphone | 19 | $4,221 | $222 |
| Morphine Sulfate Er | 33 | $3,662 | $111 |
| Quetiapine | 40 | $3,485 | $87 |
| Hydromorphone | 85 | $3,396 | $40 |
| Vyvanse | 13 | $2,960 | $228 |
| Gabapentin | 87 | $2,785 | $32 |
| Fentanyl | 16 | $2,769 | $173 |
| Escitalopram | 70 | $1,484 | $21 |
| Bupropion Xl | 39 | $1,211 | $31 |
| Clonazepam | 86 | $1,084 | $13 |
| Haloperidol | 21 | $1,000 | $48 |
| Amphetamine Salt Combo | 15 | $961 | $64 |
| Tramadol | 44 | $818 | $19 |
| Fluoxetine | 39 | $566 | $15 |
| Alprazolam | 63 | $542 | $9 |
| Acetaminophen-Codeine | 15 | $497 | $33 |
| Buspirone | 23 | $492 | $21 |
| Risperidone | 27 | $438 | $16 |
| Trazodone | 40 | $302 | $8 |
| Lorazepam | 45 | $294 | $7 |
| Mirtazapine | 21 | $280 | $13 |
| Cyclobenzaprine | 17 | $265 | $16 |
| Sertraline | 31 | $257 | $8 |
| Diclofenac | 11 | $251 | $23 |
| Carisoprodol | 11 | $223 | $20 |
| Methadone | 17 | $207 | $12 |
| Zolpidem | 38 | $204 | $5 |
| Lamotrigine | 18 | $171 | $10 |
| Benztropine Mesylate | 19 | $150 | $8 |
| Citalopram Hbr | 14 | $91 | $7 |
| Meloxicam | 19 | $80 | $4 |
| Diazepam | 14 | $68 | $5 |
2013: 31 drugs
| Cymbalta | 56 | $14,107 | $252 |
| Oxycontin | 13 | $6,124 | $471 |
| Lidoderm | 11 | $4,011 | $365 |
| Hydromorphone | 72 | $3,022 | $42 |
| Hydrocodone-Acetaminophen | 151 | $2,934 | $19 |
| Morphine Sulfate Er | 33 | $2,183 | $66 |
| Gabapentin | 69 | $2,181 | $32 |
| Tramadol Hcl Er | 14 | $1,732 | $124 |
| Oxycodone | 34 | $1,684 | $50 |
| Quetiapine | 35 | $1,311 | $37 |
| Risperidone | 37 | $1,169 | $32 |
| Tramadol | 23 | $765 | $33 |
| Methylphenidate | 13 | $712 | $55 |
| Escitalopram | 34 | $661 | $19 |
| Fluoxetine | 55 | $449 | $8 |
| Clonazepam | 53 | $430 | $8 |
| Bupropion Xl | 15 | $407 | $27 |
| Acetaminophen-Codeine | 13 | $340 | $26 |
| Oxycodone-Acetaminophen | 11 | $280 | $25 |
| Mirtazapine | 19 | $266 | $14 |
| Meloxicam | 18 | $202 | $11 |
| Lamotrigine | 17 | $195 | $11 |
| Alprazolam | 29 | $195 | $7 |
| Cyclobenzaprine | 11 | $191 | $17 |
| Lorazepam | 32 | $191 | $6 |
| Trazodone | 19 | $189 | $10 |
| Carisoprodol | 18 | $182 | $10 |
| Zolpidem | 20 | $131 | $7 |
| Sertraline | 16 | $131 | $8 |
| Citalopram Hbr | 12 | $75 | $6 |
| Diazepam | 14 | $69 | $5 |
Money from drug and device companies
$601 in 2025
| 2025 | 10 | 15 | None | $601 |
| 2024 | 4 | 19 | None | $846 |
| 2023 | 9 | 17 | None | $564 |
| 2022 | 8 | 25 | None | $625 |
| 2021 | 15 | 34 | $20 | $629 |
| 2020 | 21 | 37 | None | $827 |
| 2019 | 18 | 42 | None | $856 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Wavewriter Alpha Prime 16 | $199 | 4 payments
|
| SPR Therapeutics | Sprint Pns System | $134 | 1 payment
|
| Novo Nordisk | Wegovy | $90 | 3 payments
|
| Vertex Pharmaceuticals | Journavx | $34 | 1 payment
|
| Saluda Medical Americas | Evoke | $33 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $30 | 1 payment
|
See all 15 published payments
| Boston Scientific | Meals · 2025-12-03 | Wavewriter Alpha Prime 16 | $39 |
| Novo Nordisk | Meals · 2025-11-06 | Wegovy | $33 |
| Boston Scientific | Meals · 2025-10-22 | Wavewriter Alpha Prime 16 | $51 |
| Novo Nordisk | Meals · 2025-10-09 | Wegovy | $28 |
| SPR Therapeutics | Meals · 2025-09-06 | Sprint Pns System | $134 |
| Boston Scientific | Meals · 2025-08-27 | Wavewriter Alpha Prime 16 | $51 |
| Boston Scientific | Meals · 2025-08-27 | Wavewriter Alpha Prime 16 | $58 |
| Novo Nordisk | Meals · 2025-08-14 | Wegovy | $29 |
| Vertex Pharmaceuticals | Meals · 2025-07-15 | Journavx | $34 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-27 | Relistor | $30 |
| Merck Sharp & Dohme | Meals · 2025-04-24 | Verquvo | $22 |
| Scilex Pharmaceuticals | Meals · 2025-03-11 | Ztlido | $23 |
| Lilly USA | Meals · 2025-03-06 | Mounjaro | $21 |
| Abbott Laboratories | Meals · 2025-02-06 | Ionicrf | $16 |
| Saluda Medical Americas | Meals · 2025-01-07 | Evoke | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $846
| Boston Scientific | Wavewriter Alpha Prime 16 | $712 | 12 payments
|
| SPR Therapeutics | Sprint Pns System | $73 | 1 payment
|
| Abbott Laboratories | Eterna | $39 | 2 payments
|
| Electronic Waveform Lab | None | $22 | 2 payments
|
2023: $564
| Boston Scientific | Wavewriter Alpha Prime 16 | $292 | 6 payments
|
| Abbott Laboratories | Eterna | $62 | 2 payments
|
| AbbVie | Botox | $59 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $40 | 2 payments
|
| Collegium Pharmaceutical | Belbuca | $24 | 1 payment
|
| Virtus Pharmaceuticals | Levorphanol Tartrate | $24 | 1 payment
|
| Averitas Pharma | Qutenza | $22 | 1 payment
|
| Pfizer | Nurtec Odt | $21 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $19 | 1 payment
|
2022: $625
| Boston Scientific | Wavewriter Alpha Prime 16 | $221 | 5 payments
|
| Abbott Laboratories | Proclaim | $144 | 10 payments
|
| Abbvie | Botox | $70 | 3 payments
|
| Lundbeck | Rexulti | $60 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $50 | 2 payments
|
| Medtronic | Intellis Adaptivestim | $41 | 1 payment
|
| Harmony Biosciences | Wakix | $26 | 1 payment
|
| Stratus Medical | Nimbus | $13 | 1 payment
|
2021: $629
| AbbVie | Vraylar | $117 | 7 payments
|
| Eisai | Dayvigo | $79 | 4 payments
|
| Medtronic | Intellis | $70 | 5 payments
|
| Lundbeck | Vyepti | $66 | 3 payments
|
| BioDelivery Sciences International | Belbuca | $56 | 3 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $49 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $42 | 2 payments
|
| Amgen | Aimovig | $26 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $20 | 1 payment
|
| McKesson Medical-Surgical | None | $20 | 1 payment
|
| Bioventus | Durolane | $17 | 1 payment
|
| Abbott Laboratories | Proclaim Ipg | $17 | 1 payment
|
| Stryker | Multigen 2 | $17 | 1 payment
|
| Boston Scientific | General Pain Management | $17 | 1 payment
|
| Alfasigma USA | None | $16 | 1 payment
|
2020: $827
| Nevro | Senza Spinal Cord Stimulation System | $140 | 1 payment
|
| Eisai | Dayvigo | $73 | 3 payments
|
| Biodelivery Sciences International | Belbuca | $73 | 4 payments
|
| Allergan | Ubrelvy | $67 | 4 payments
|
| Lundbeck | Brintellix | $63 | 3 payments
|
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $51 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $48 | 2 payments
|
| Medtronic USA | Adaptivestim | $47 | 2 payments
|
| Arbor Pharmaceuticals | Edarbi | $40 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $25 | 1 payment
|
| Sunovion Pharmaceuticals | Latuda | $24 | 1 payment
|
| Amarin Pharma | Vascepa | $23 | 1 payment
|
| Alkermes | Aristada | $20 | 1 payment
|
| Sun Pharmaceutical Industries | Kapspargo | $20 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $19 | 1 payment
|
| Forte Bio-Pharma | Nalocet | $18 | 1 payment
|
| Sentynl Therapeutics | Levorphanol Tartrate | $17 | 1 payment
|
| RedHill Biopharma | Movantik | $17 | 1 payment
|
| Alfasigma USA | None | $16 | 1 payment
|
| Horizon Therapeutics plc | Duexis | $15 | 1 payment
|
| Boston Scientific | Spectra Wavewriter | $11 | 1 payment
|
2019: $856
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $172 | 2 payments
|
| Sunovion Pharmaceuticals | Latuda | $126 | 12 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $96 | 3 payments
|
| Horizon Therapeutics plc | Duexis | $72 | 5 payments
|
| Allergan | Vraylar | $38 | 2 payments
|
| Medtronic USA | Adaptivestim | $36 | 1 payment
|
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $35 | 2 payments
|
| Novartis Pharmaceuticals | Aimovig | $35 | 2 payments
|
| Alkermes | Vivitrol | $35 | 2 payments
|
| Sentynl Therapeutics | Levorphanol Tartrate | $34 | 2 payments
|
| Boston Scientific | General Therapies | $33 | 2 payments
|
| DePuy Synthes Sales | Orthovisc | $27 | 1 payment
|
| Avanos Medical | Coolief* Cooled Radiofrequency | $27 | 1 payment
|
| GRT US Holding | Qutenza | $23 | 1 payment
|
| Amgen | Aimovig | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $18 | 1 payment
|
| Assertio Therapeutics | Gralise | $14 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $11 | 1 payment
|
Professional record
- NPI
- 1821279423
- Licence
- CA A109016California A109016: Current · expires 2026-12-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P2900X (2084P2900X); Psychiatry (2084P0800X); Federal specialty code 208VP0014X (208VP0014X)
- Mailing address
- 23150 Crenshaw Blvd Ste 100, Torrance, CA, 90505
- NPI first listed
- 2007-11-25
- NPI last updated
- 2024-03-22
- NPI record certified
- 2024-03-22
This is when the NPI record was last certified, not a medical board exam.